Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-10 Sale |
2021-05-12 5:06 pm |
Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer |
2,229 | $7.23 | $16,116 | 220,719 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-16 5:11 pm |
Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer |
4,520 | $11.8 | $53,336 | 103,956 (Direct) |
View |
| 2021-01-28 Sale |
2021-01-29 8:19 pm |
Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer |
2,624 | $12.55 | $32,931 | 88,376 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 6:02 pm |
Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer |
4,005 | $11.13 | $44,576 | 73,455 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 5:58 pm |
Flexion Therapeutics Inc | FLXN | KELLEY SCOTT Chief Medical Officer |
6,829 | $11.13 | $76,007 | 113,549 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 5:56 pm |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
6,829 | $11.13 | $76,007 | 119,767 (Indirect Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 5:55 pm |
Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer |
6,602 | $11.13 | $73,480 | 115,186 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 5:52 pm |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
6,829 | $11.13 | $76,007 | 107,431 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 5:50 pm |
Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer |
6,073 | $11.13 | $67,592 | 151,048 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-06-03 4:14 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | DRISCOLL FREDERICK W Chief Financial Officer |
0 | $0 | 2,680 (Direct) |
View |
| 2021-01-08 Gift |
2021-03-23 7:01 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
25,861 | $0 | 1,134,192 (Direct) |
View |
| 2021-01-15 Other(A) |
2021-03-12 5:10 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | COLELLA SAMUEL D Director |
2,198 | $0 | 79,983 (Indirect) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:42 pm |
N/A 2031-02-28 |
Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer |
50,000 | $0 | 123,455 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:35 pm |
N/A 2031-02-28 |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
50,000 | $0 | 169,767 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:33 pm |
N/A 2031-02-28 |
Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer |
50,000 | $0 | 165,186 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:31 pm |
N/A 2031-02-28 |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
50,000 | $0 | 157,431 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:29 pm |
N/A 2031-02-28 |
Flexion Therapeutics Inc | FLXN | KELLEY SCOTT Chief Medical Officer |
50,000 | $0 | 163,549 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:26 pm |
N/A 2031-02-28 |
Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer |
91,900 | $0 | 242,948 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:22 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer |
50,250 | $0 | 138,626 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:16 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
265,250 | $0 | 1,293,342 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 8:19 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer |
30,000 | $0 | 88,376 (Direct) |
View |
| 2021-01-28 Tax Withholding |
2021-01-29 8:17 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
8,776 | $12.37 | 1,028,092 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 8:17 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
119,500 | $0 | 1,028,092 (Direct) |
View |
| 2021-01-15 Other |
2021-01-20 7:09 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | COLELLA SAMUEL D Director |
3,203,469 | $0 | 4,276,365 (Indirect) |
View |
| 2021-01-05 Tax Withholding |
2021-01-07 5:47 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
2,530 | $0 | 917,368 (Direct) |
View |
| 2020-07-08 Gift |
2021-01-07 5:47 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
1,303 | $0 | 917,368 (Direct) |
View |
Ownership |
2021-01-06 4:14 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer |
0 | $0 | 170,127 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 4:47 pm |
N/A 2030-08-17 |
Flexion Therapeutics Inc | FLXN | Kwo Elizabeth Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:33 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer |
38,750 | $0 | 157,121 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:31 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | KELLEY SCOTT Chief Medical Officer |
38,750 | $0 | 119,710 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:28 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer |
38,750 | $0 | 121,788 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:26 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
93,750 | $0 | 919,898 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:24 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
38,750 | $0 | 114,260 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:23 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
38,750 | $0 | 126,180 (Direct) |
View |
| 2020-07-09 Exercise |
2020-07-10 4:06 pm |
N/A 2021-05-19 |
Flexion Therapeutics Inc | FLXN | MILINAZZO ALAN Director |
18,450 | $0 | 22,950 (Direct) |
View |
| 2020-07-09 Exercise |
2020-07-10 4:06 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | MILINAZZO ALAN Director |
18,450 | $2.1951 | 22,950 (Direct) |
View |
| 2020-06-09 Other |
2020-06-24 4:23 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer |
435 | $0 | 83,473 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 4:21 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer |
1,303 | $10.83 | 118,371 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 4:18 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
1,303 | $10.83 | 826,148 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 4:15 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | KELLEY SCOTT Chief Medical Officer |
595 | $10.83 | 80,960 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 4:12 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
1,023 | $10.83 | 75,510 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 4:09 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
369 | $10.83 | 87,430 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 4:25 pm |
N/A 2030-06-09 |
Flexion Therapeutics Inc | FLXN | Stejbach Mark Director |
11,500 | $0 | 15,131 (Direct) |
View |